# Clinical Dataset Adaptation

This pipeline provides a reusable preprocessing framework, not a fixed clinical standard. Below I outline what transfers well, what would need to change, and how I would adapt it for Parkinson's research.

TL;DR: The framework and validation philosophy transfer directly. The endpoint definition, temporal logic, and cohort-specific quality control would need to be redesigned for each clinical question.

The current pipeline is a strong reproducible baseline for self-supervised learning, representation learning, and early supervised modelling, but it is not intended as a finished disease-specific preprocessing standard. For clinical deployment or higher-stakes disease-modelling studies, the reusable part is the preprocessing framework and validation philosophy; the disease-specific part is the label strategy, temporal design, and cohort-aware quality control.

## What Transfers Well

Several design choices in this repository carry over directly to clinical and biobank datasets:

- **Subject-level provenance**: already supports leakage-aware splitting across repeated measures and linked modalities.
- **Fixed-shape signal outputs**: useful for downstream SSL and neural sequence models that expect inspectable tensor contracts.
- **Machine-readable manifests and reports**: helpful for auditability, controlled-access workflows, and reruns on large cohorts.
- **Chunked and resumable processing**: important for multi-GB wearable, waveform, and linked-record datasets.
- **Validation before modelling**: a strong default for catching schema drift, malformed arrays, and split leakage before training begins.
- **Modular parser layout**: makes it practical to add cohort-specific ingestion code without rewriting the whole pipeline.

## What Would Need To Change For Clinical Use

Clinical extension is not just a parser problem. Clinical extension typically requires changes in five areas:

- **Endpoint definition**: labels may be diagnosis-based, progression-based, medication-state-based, or time-to-event rather than simple activity or record labels.
- **Temporal design**: visit dates, prescription dates, wearable windows, and diagnosis dates must be aligned carefully to avoid future-information leakage.
- **Missing-data policy**: non-wear, missed visits, incomplete assessments, and irregular follow-up need explicit handling rules.
- **Artifact strategy**: clinical wearables and biosignals may need cohort-specific QC rules that go beyond the light defaults used here.
- **Security and governance**: controlled-access environments often require different storage, logging, and credential-handling patterns than open-data workflows.

## Parkinson's-Specific Considerations

For Parkinson's research, several issues become especially important:

- **Longitudinal leakage**: repeated visits from the same participant must not be split in a way that leaks future state into training.
- **Medication timing**: motor signals can differ substantially between ON and OFF medication states, so timing metadata may need to be preserved and validated explicitly.
- **Prodromal vs diagnosed labels**: the scientific meaning of the target can change depending on whether the task is early detection, subtype discrimination, progression modelling, or symptom monitoring.
- **Non-wear and adherence**: wearable-derived signals may reflect compliance patterns as much as physiology unless wear-time QC is handled carefully.
- **Multimodal alignment**: wearable, clinical, prescription, imaging, and EHR data often live on different timelines and require explicit synchronization logic.

## Example Adaptations

### UK Biobank Accelerometry
- **What transfers directly**: chunked processing, provenance preservation, validation-first workflow.
- **What changes**: parser logic for UK Biobank formats, epoch structure, and cohort-specific metadata conventions.
- **Extra validation needed**: wear-time checks, day-level completeness summaries, and leakage-safe participant splits.

### PPMI Wearables
- **What transfers directly**: signal-level outputs, subject-aware metadata, modular parser pattern.
- **What changes**: handling of proprietary or cohort-specific formats, visit structure, and medication-state context.
- **Extra validation needed**: visit ordering checks, patient-level split enforcement, and timing consistency between sensor and clinical labels.

### EHR-Linked Cohorts
- **What transfers directly**: manifest generation, reproducibility tracking, and leakage-aware metadata design.
- **What changes**: event extraction, coding-system normalization, temporal joins, and representation choices for sparse longitudinal records.
- **Extra validation needed**: no future-code leakage, temporal ordering sanity checks, and cohort/site balance summaries.

### Prescription Data
- **What transfers directly**: provenance tracking and modular ingestion design.
- **What changes**: temporal alignment to visits, diagnoses, and wearable windows.
- **Extra validation needed**: impossible-date checks, overlap windows, and medication-exposure summaries.

## Additional Validation Needed In Clinical Work

If this repository were extended into a real clinical modelling pipeline, I would add at least the following checks:

- **No patient leakage across visits, sites, or linked modalities**
- **No future information in train labels or derived covariates**
- **Visit/order consistency for longitudinal records**
- **Missingness and wear-time summaries**
- **Cohort or site imbalance checks**
- **Task-specific quality-control rules for artifacts and invalid segments**

## Practical Next Steps

To extend this repository for a Parkinson's-focused programme, my first implementation steps would be:

1. Add cohort-specific parsers while preserving the existing output contract where possible.
2. Define the exact clinical endpoint and temporal prediction design before changing labels.
3. Add explicit longitudinal leakage and timing validation.
4. Add cohort-specific QC summaries for non-wear, missing visits, and artifact burden.
5. Only then tune task-specific preprocessing beyond the current baseline.

In short, this repository already provides a sound engineering foundation for clinical adaptation. What would need to become more specific is not the overall pipeline philosophy, but the endpoint definition, temporal logic, and validation depth required by the target clinical question.
